SEC Form 4 research

Sionna Therapeutics, Inc. insider transactions

IssuerSionna Therapeutics, Inc.
TickersSION
Reporting owners31
Officers and directors7
Last public filing2026-09-21

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-09-212026-09-17Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., RA Capital Nexus Fund, L.P., Shah Rajeev M.S33,800$7.46Not reported
2026-09-212026-09-17Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., RA Capital Nexus Fund, L.P., Shah Rajeev M.S3,415,011$6.32Not reported
2026-09-182026-09-17Ridloff ElenaA47,268$0Not reported
2026-09-182026-09-17Ridloff ElenaA47,269$0Not reported
2026-09-182026-09-17Ridloff ElenaA165,440$0Not reported
2026-09-182026-09-17McKee CharlotteA50,000$0Not reported
2026-09-182026-09-17McKee CharlotteA50,000$0Not reported
2026-09-182026-09-17McKee CharlotteA155,700$0Not reported
2026-09-182026-09-17Fitzpatrick JenniferA28,132$0Not reported
2026-09-182026-09-17Fitzpatrick JenniferA28,133$0Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page